HIM
PFE icon

Hermes Investment Management’s Pfizer PFE Stock Holding History

Hermes Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$30.6M Buy
890,397
+149,377
+20% +$5.1M 0.41% 87
2018
Q1 		$25M Buy
741,020
+22,818
+3% +$784K 0.36% 98
2017
Q4 		$24.7M Buy
718,202
+4,862
+0.7% +$166K 0.35% 100
2017
Q3 		$24.2M Buy
713,340
+118,840
+20% +$3.82M 0.36% 96
2017
Q2 		$18.9M Buy
594,500
+3,660
+0.6% +$115K 0.31% 108
2017
Q1 		$19.2M Sell
590,840
-6,831
-1% -$215K 0.31% 111
2016
Q4 		$18.4M Buy
597,671
+22,647
+4% +$691K 0.31% 114
2016
Q3 		$18.5M Buy
575,024
+268,594
+88% +$8.98M 0.31% 112
2016
Q2 		$10.2M Buy
306,430
+77,574
+34% +$2.48M 0.21% 128
2016
Q1 		$6.52M Buy
228,856
+27,643
+14% +$790K 0.14% 133
2015
Q4 		$6.16M Buy
201,213
+61,934
+44% +$1.95M 0.14% 130
2015
Q3 		$4.15M Sell
139,279
-648,682
-82% -$20.8M 0.11% 127
2015
Q2 		$25.1M Hold
787,961
– – 0.56% 86
2015
Q1 		$26M Buy
787,961
+40,052
+5% +$1.27M 0.6% 79
2014
Q4 		$22.1M Hold
747,909
– – 0.57% 78
2014
Q3 		$21M Buy
747,909
+147,084
+24% +$4.13M 0.54% 87
2014
Q2 		$16.9M Buy
600,825
+505,498
+530% +$14.4M 0.47% 99
2014
Q1 		$2.9M Buy
95,327
+5,634
+6% +$168K 0.09% 112
2013
Q4 		$2.61M Hold
89,693
– – 0.08% 110
2013
Q3 		$2.44M Sell
89,693
-24,845
-22% -$676K 0.08% 106
2013
Q2 		$3.04M Buy
+114,538
New +$3.16M 0.12% 107

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hermes Investment Management's PFE Position: Q2 2018 in Review

Hermes Investment Management increased its Pfizer (PFE) stake by 20% in Q2 2018, buying an estimated $5.1M and bringing the position to 890,397 shares worth $30.6M. The position accounts for 0.41% of the portfolio, ranked #87.

Hermes Investment Management first reported a position in PFE in Q2 2013 and has held it in 21 quarters since. 2,204 funds tracked by Wall St. Rank hold PFE as of Q2 2018.

  • Hermes Investment Management held 890,397 shares of Pfizer worth $30.6M as of Q2 2018.
  • Hermes Investment Management bought 149,377 Pfizer shares in Q2 2018, an estimated $5.1M.
  • Pfizer made up 0.41% of Hermes Investment Management's portfolio in Q2 2018, its #87 holding.
  • Hermes Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 21 quarters since.
  • 2,204 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.

Based on Hermes Investment Management's 13F filing for Q2 2018, filed 24 Jul 2018.